RecallClass 3 · Action within 5 days

Class 3 Medicines Recall: Aspire Pharma Limited, Tropicamide 1% Eye Drops, solution in single dose containers 20 x 0.5ml , EL(26)A/47

Issued 5 Nov 2026 · EL(26)A/47 · Aspire Pharma Ltd

Read and act on the official notice on GOV.UK

Print a recall checklist One A4 sheet to work through the shelves and keep as your record.

Class 3 recall — Action within 5 days. The MHRA uses Class 3 when: The defect is unlikely to cause harm to the patient.
What all four recall classes mean
ClassActionThe MHRA's definition
Class 1Immediate actionThe defect presents a risk of death or disability.
Class 2Action within 48 hoursThe defect may cause mistreatment or harm to the patient, but it is not life-threatening or serious.
Class 3 this recallAction within 5 daysThe defect is unlikely to cause harm to the patient.
Class 4Caution in useUsually minor defects in packaging or other printed materials.

A Class 1 recall usually comes with a National Patient Safety Alert. Source: MHRA, safety communications.

In plain English, for the pharmacy team

Why is this relevant to community pharmacy

Tropicamide 1% Eye Drops are eye drops used in eye care. Aspire Pharma Ltd is recalling the batches listed in the notice because some packs have the wrong expiry date printed on them. This affects pharmacy stock and any patients who may already have these eye drops.

What to tell patients

Use your professional judgement for each patient.

  • No further action is required by patients.
  • If you have these eye drops, continue to use them and contact your prescriber to get a replacement prescription.
  • If you have any side effects or questions about your medicine, seek medical attention.
  • Any suspected side effects should also be reported via the Medicines and Healthcare products Regulatory Agency (MHRA) Yellow Card scheme.

What needs to be done

  • Stop supplying the batches listed in the notice straight away.
  • Quarantine any remaining stock of the batches listed in the notice.
  • Return the quarantined stock to your supplier using your supplier’s approved process.
  • Pharmacists: if patients or staff report a suspected adverse reaction, report it through the MHRA Yellow Card scheme.
  • Read and act on the official GOV.UK notice.

Pharmshark summary, checked and approved by Chris Dotchin on 6 Nov 2026. It is not the official notice: always read and act on the GOV.UK notice.

How this summary was written

An AI tool drafted it from the MHRA's own notice and nothing else. A second check compared every line with the notice. Pharmshark's clinical lead then read it against the notice, edited it where needed and approved it. If the MHRA changes the notice, this summary is taken down until it has been checked again.

The MHRA's summary

Aspire Pharma Ltd is recalling specific batches of Tropicamide 1% Eye Drops, solution in single dose containers 0.5ml x 20, due to them being labelled with the incorrect expiry date. The correct expiry date for these batches should be 31/10/2026.

Affected batches

As listed by the MHRA, exactly as published. Always check against the GOV.UK notice before acting.

Batch numberExpiryPack sizeFirst distributed
Tropicamide 1% Eye Drops, solution in single dose containers 20 x 0.5ml
E941A30/04/2027*2029/10/2025
E941B30/04/2027*2004/02/2026
E941C30/04/2027*2020/02/2026

Open the official GOV.UK notice

MHRA's audience tags: Dispensing GP practices, Pharmacy

Pharmshark is not an official alerting route. Make sure your pharmacy receives alerts directly from the MHRA and through your organisation, and always act on the official GOV.UK notice.

Source: the MHRA on GOV.UK. Contains public sector information licensed under the Open Government Licence v3.0. Pharmshark is not affiliated with or endorsed by the MHRA.